NCT00579228View on ClinicalTrials.gov

Vascular Risk Progression in Normal and Diabetic Control Subjects.

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

April 25, 2007

Primary Completion Date

March 29, 2018

Study Completion Date

March 29, 2018

Conditions
DiabetesInflammation
Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER

NCT00579228 - Vascular Risk Progression in Normal and Diabetic Control Subjects. | Biotech Hunter | Biotech Hunter